| P2093 | author name string | Andrew H Miller | |
| P2860 | cites work | Mood and cognitive disorders in cancer patients receiving cytokine therapy | Q33708121 |
| | Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression | Q33708129 |
| | Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress | Q33708133 |
| | Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways | Q33715487 |
| | Glial activation: a driving force for pathological pain | Q33953790 |
| | Cytokine-induced sickness behavior: where do we stand? | Q34190014 |
| | Sickness behavior as a new target for drug development | Q35899947 |
| | The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function | Q40685855 |
| | Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment | Q42517860 |
| | Paroxetine for the prevention of depression induced by high-dose interferon alfa | Q43556890 |
| | Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. | Q43562225 |
| | Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. | Q43942974 |
| | Assessment and treatment of depression in the cancer patient | Q48374918 |
| | Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer | Q48800678 |
| | Mind matters -- group therapy and survival in breast cancer | Q77347379 |
| P304 | page(s) | S132-4 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Brain, Behavior, and Immunity | Q15716593 |
| P1476 | title | Cytokines and sickness behavior: implications for cancer care and control | |
| P478 | volume | 17 Suppl 1 | |